![]() | |
Clinical data | |
---|---|
ATC code |
|
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChemCID | |
ChemSpider | |
UNII | |
KEGG | |
CompTox Dashboard(EPA) | |
Chemical and physical data | |
Formula | C21H11F6N5 |
Molar mass | 447.344 g·mol−1 |
3D model (JSmol) | |
| |
|
Decoglurant (INN) (code nameRG1578,RO4995819) is anegative allosteric modulator of themGlu2 andmGlu3 receptors which was under development byRoche for theadjunctive treatment ofmajor depressive disorder.[1][2] Decoglurant progressed as far asphase IIclinical trials[1][2] but was ultimately discontinued from further development due to disappointing efficacy results.[3][4]
![]() | Thisdrug article relating to thenervous system is astub. You can help Wikipedia byexpanding it. |